Skip to main content
SpringerLink
Log in

Mesothelial and Mesothelioma Cell Lines

  • Chapter
Malignant Mesothelioma

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Versnel MA, van der Kwast TH, Hoogsteden HC, et al. Establishment and characteristics of human normal and malignant mesothelial cell lines. In: Jaurand M-C, Bignon J, eds. The Mesothelial Cell and Mesothelioma. New York: Marcel Dekker, 1994:169–186.

    Google Scholar 

  2. Masters JRW. Human cancer cell lines: fact and fantasy. Nature Rev Mol Cell Biol 2000;1:233–236.

    Article  CAS  Google Scholar 

  3. Manning LS, Whitaker D, Murch AR, et al. Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions. Int J Cancer 1991;47:285–290.

    PubMed  CAS  Google Scholar 

  4. Gerwin BI. Mesothelial carcinogenesis: possible avenues of growth promotion. In: Jaurand M-C, Bignon J, eds. The Mesothelial Cell and Mesothelioma. New York: Marcel Dekker, 1994:223–244.

    Google Scholar 

  5. Walker C, Bermudez E, Evertt J. Growth factor and receptor expression by mesothelial cells: a comparison between rodents and humans. In: Harris CC, Lechner JF, Brinkley BR, eds. Cellular and Molecular Aspects of Fiber Carcinogenesis. New York: Cold Spring Harbor Laboratory Press, 1991:149–158.

    Google Scholar 

  6. Gerwin BI, Lechner JF, Reddel RR, et al. Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 1987;47:6180–6184.

    PubMed  CAS  Google Scholar 

  7. Lechner JF, LaVeck MA, Gerwin BI, et al. Differential responses to growth factors by normal human mesothelial cultures from individual donors. J Cell Physiol 1989;139:295–300.

    Article  PubMed  CAS  Google Scholar 

  8. Craighead JE, Akley NJ, Gould LB, et al. Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats. Am J Pathol 1987;129:448–462.

    PubMed  CAS  Google Scholar 

  9. Bermudez E, Everitt J, Walker C. Expression of growth factor receptor RNA in rat pleural mesothelial cells in culture. Exp Cell Res 1990;190:91–98.

    Article  PubMed  CAS  Google Scholar 

  10. Mackay AM, Tracy RP, Craighead JE. Intermediate filament proteins in asbestos-induced mesotheliomas of the rat. Cancer Res 1987;47:5461–5468.

    PubMed  CAS  Google Scholar 

  11. Walker C, Rutten F, Yuan X, et al. Wilms’ tumor suppressor gene expression in rat and human mesothelioma. Cancer Res 1994;54:3101–3106.

    PubMed  CAS  Google Scholar 

  12. Zeng L, Fleury-Feith J, Monnet I, et al. Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum Pathol 1994;25:227–234.

    Article  PubMed  CAS  Google Scholar 

  13. Ordóñez NG. Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers. Hum Pathol 2002;33:953–967.

    Article  PubMed  Google Scholar 

  14. Cistulli CA, Sorger T, Marsella JM, et al. Spontaneous p53 mutation in murine mesothelial cells: increased sensitivity to DNA damage induced by asbestos and ionizing radiation. Toxicol Appl Pharmacol 1996;141:264–271.

    PubMed  CAS  Google Scholar 

  15. Lechner JF, Gerwin BI, Reddel RR, et al. Studies on human mesothelial cells: effects of growth factors and asbesti-form fibers. In: Harris CC, Lechner JF, Brinkley BR, eds. Cellular and Molecular Aspects of Fiber Carcinogenesis. New York: Cold Spring Harbor Laboratory Press, 1991:115–130.

    Google Scholar 

  16. Cano A, Pérez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76–83.

    Article  PubMed  CAS  Google Scholar 

  17. Carver EA, Jiang R, Lan Y, et al. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 2001;21:8184–8188.

    Article  PubMed  CAS  Google Scholar 

  18. Yáñez-Mó M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003;348:403–413.

    Article  PubMed  Google Scholar 

  19. Gulyás M, Dobra K, Hjerpe A. Expression of genes coding for proteoglycans and Wilms tumor susceptibility gene 1(WT1) by variously differentiated benign human mesothelial cells. Differentiation 1999;65:89–96.

    Article  PubMed  Google Scholar 

  20. Wu Y-J, Parker LM, Binder NE, et al. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 1982;31:693–703.

    Article  PubMed  CAS  Google Scholar 

  21. O’Connell ND, Rheinwald JG. Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 1983;34:245–253.

    Article  Google Scholar 

  22. Kim KH, Stellmach V, Javors J, et al. Regulation of human cell differentiation: opposing roles of retinoids and epidermal growth factor in the expression of intermediate filament proteins. J Cell Biol 1987;105:3039–3051.

    Article  PubMed  CAS  Google Scholar 

  23. Kamp DW, Graceffa P, Pryor WA, et al. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992;12:293–315.

    Article  PubMed  CAS  Google Scholar 

  24. Broaddus VC, Yang L, Scavo LM, et al. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J Clin Invest 1996;98:2050–2059.

    PubMed  CAS  Google Scholar 

  25. Bérubé KA, Quinhan TR, Fung H, et al. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am J Respir Cell Mol Biol 1996;15:141–147.

    Article  PubMed  Google Scholar 

  26. Lechner JF, Tokimwa T, LaVeck M, et al. Asbestos-associated chromosomal changes in human mesothelial cells. Proc Natl Acad Sci USA 1985;82:3884–3888.

    Article  PubMed  CAS  Google Scholar 

  27. Fung H, Kow YW, Van Houten B, et al. Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidant stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos. Carcinogenesis 1997;18:825–832.

    Article  PubMed  CAS  Google Scholar 

  28. Ollikainen T, Linnainmaa K, Kinnula VL. DNA single strand breaks induced by asbestos fibers in human pleural mesothelial cells in vitro. Environ Mol Mutagenesis 1999;33:153–160.

    Article  CAS  Google Scholar 

  29. Driscoll KE, Carter JM, Borm PJA. Antioxidant defense mechanisms and the toxicity of fibrous and nonfibrous particles. Inhal Toxicol 2002;14:101–118.

    Article  PubMed  CAS  Google Scholar 

  30. Kinnula VL, Everitt JI, Mangum JB, et al. Antioxidant defense mechanisms in cultured pleural mesothelial cells. Am J Respir Cell Mol Biol 1992;7:95–103.

    PubMed  CAS  Google Scholar 

  31. Jaurand M-C, Barrett JC. Neoplastic transformation of mesothelial cells. In: Jaurand M-C, Bignon J, eds. The Mesothelial Cell and Mesothelioma. New York: Marcel Dekker, 1994:207–222.

    Google Scholar 

  32. Jaurand M-C, Saint-Etienne L, Van der Meeren A, et al. Neoplastic transformation of rodent cells. In: Harris CC, Lechner JF, Brinkley BR, eds. Cellular and Molecular Aspects of Fiber Carcinogenesis. New York: Cold Spring Harbor Laboratory Press, 1991:131–148.

    Google Scholar 

  33. Funaki K, Everitt J, Bermudez E, et al. Trisomy of rat chromosome 1 associated with mesothelial cell transformation. Cancer Res 1991;51:4059–4066.

    PubMed  CAS  Google Scholar 

  34. Ke Y, Reddel RR. Gerwin BI, et al. Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestosinduced mesothelioma. Am J Pathol 1989;134:979–991.

    PubMed  CAS  Google Scholar 

  35. Dickson MA, Hahn WC, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000;20:1436–1447.

    Article  PubMed  CAS  Google Scholar 

  36. Bocchetta M, DiResta I, Powers A, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci USA 2000;97:10214–10219.

    Article  PubMed  CAS  Google Scholar 

  37. Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983;304:596–602.

    Article  PubMed  CAS  Google Scholar 

  38. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med 2002;347:1593–1603.

    Article  PubMed  CAS  Google Scholar 

  39. Tubo RA, Rheinwald JG. Normal human mesothelial cells and fibroblasts transfected with the EJras oncogene become EGF-independent, but are not malignantly transformed. Oncogene Res 1987;1:407–421.

    PubMed  CAS  Google Scholar 

  40. Reddel RR, Malan-Shibley L, Gerwin BI, et al. Tumorigenicity of human mesothelial cell line transfected with EJ-ras oncogene. J Natl Cancer Inst 1989;81:945–948.

    PubMed  CAS  Google Scholar 

  41. O’Connell TM, Rheinwald JG. Biology of normal, malignant, and oncogene-transfected human mesothelial cells in culture. In: Harris CC, Lechner JF, Brinkley BB, eds. Cellular and Molecular Aspects of Fiber Carcinogenesis. New York: Cold Spring Harbor Laboratory Press, 1991:55–66.

    Google Scholar 

  42. Yu J, Boyapati A, Rundell K. Critical role for SV40 small-t antigen in human cell transformation. Virology 2001;290:192–198.

    Article  PubMed  CAS  Google Scholar 

  43. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57–70.

    Article  PubMed  CAS  Google Scholar 

  44. Kane, AB. Mechanisms of mineral fibre carcinogenesis. In: Kane AB, Boffetta P, Saracci R, Wilbourn JD, eds. Mechanisms of Fibre Carcinogenesis. Lyon: IARC Scientific Publications No. 140, 1996:11–34.

    Google Scholar 

  45. Dhaene K, Hübner R, Kumar-Singh S, et al. Telomerase activity in human pleural mesothelioma. Thorax 1998;53:915–918.

    Article  PubMed  CAS  Google Scholar 

  46. Dhaene K, Wauters J, Weyn B, et al. Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 2000;190:80–85.

    Article  PubMed  CAS  Google Scholar 

  47. Kane AB. Animal models of malignant mesothelioma. In: Rom WN, ed. Environmental and Occupational Medicine, 3rd ed. Philadelphia: Lippincott-Raven, 1998:377–386.

    Google Scholar 

  48. Kane AB. Oncogenes and tumor suppressor genes in the carcinogenicity of fibers and particles. Inhal Toxicol 2000;12:133–140.

    Article  CAS  Google Scholar 

  49. Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001;193:F23–F26.

    Article  PubMed  CAS  Google Scholar 

  50. Tlsty TD. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 2001;11:97–104.

    Article  PubMed  CAS  Google Scholar 

  51. Goodglick LA, Vaslet CA, Messier NJ, Kane AB. Growth factor responses and protooncogene expression of murine mesothelial cell lines derived from asbestos-induced mesotheliomas. Toxicol Pathol 1997;25:565–573.

    Article  PubMed  CAS  Google Scholar 

  52. Miller LD, Long PM, Wong L, et al. Optimal gene expression analysis by microarrays. Cancer Cell 2002;2:353–361.

    Article  PubMed  CAS  Google Scholar 

  53. Castor CW, Naylor B. Characteristics of normal and malignant human mesothelial cells studied in vitro. Lab Invest 1969;20:437–443.

    PubMed  CAS  Google Scholar 

  54. Thiollet J, Jaurand MC, Kaplan H, et al. Culture procedure of mesothelial cells from the rat parietal pleura. Biomedicine 1978;29:69–73.

    PubMed  CAS  Google Scholar 

  55. Antony VB, Owen, CL, Hadley KJ. Pleural mesothelial cells stimulated by asbestos release chemotactic activity for neutrophils in vitro. Am Rev Respir Dis 1989;139:199–206.

    PubMed  CAS  Google Scholar 

  56. Stylianou E, Jenner LA, Davies M, et al. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990;37:1563–1570.

    PubMed  CAS  Google Scholar 

  57. Jonjic N, Peri G, Bernasconi S, et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992;176:1165–1174.

    Article  PubMed  CAS  Google Scholar 

  58. Gormley IP, Bolton RE, Brown G, et al. Studies on the morphological patterns of asbestos induced mesotheliomas “in vivo” and “in vitro.” Carcinogenesis 1980;2:219–231.

    Google Scholar 

  59. Whitaker D, Shilkin KB, Walters MNI. Cytologic and tissue culture characteristics of asbestos-induced mesothelioma in rats. Acta Cytol 1984;28:185–189.

    PubMed  CAS  Google Scholar 

  60. Davis MR, Manning LS, Whitaker D, et al. Establishment of a murine model of malignant mesothelioma. Int J Cancer 1992;52:881–886.

    PubMed  CAS  Google Scholar 

  61. Versnel MA, Bouts MJ, Hoogsteden HC, et al. Establishment of human malignant mesothelioma cell lines. Int J Cancer 1989;44:256–260.

    PubMed  CAS  Google Scholar 

  62. Demetri GD, Zenzie BW, Rheinwald JG, et al. Expression of colonystimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cell lines in vitro. Blood 1989;74:940–946.

    PubMed  CAS  Google Scholar 

  63. Pelin-Enlund K, Husgafvel-Pursiainen K, Tammilehto L, et al. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis 1990;11:673–681.

    PubMed  CAS  Google Scholar 

  64. Schmitter D, Lauber B, Fagg B, et al. Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int J Cancer 1992;51:296–301.

    PubMed  CAS  Google Scholar 

  65. Taguchi T, Jhanwar SC, Siegfried JM, et al. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 1993;53:4349–4355.

    PubMed  CAS  Google Scholar 

  66. Zeng L, Buard A, Monnet I, et al. In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines. Int J Cancer 1993;55:515–520.

    PubMed  CAS  Google Scholar 

  67. Xu L, Flynn BJ, Ungar S, et al. Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis 1999;20:773–783.

    Article  PubMed  CAS  Google Scholar 

  68. Pass H, Stevens E, Oie H, et al. Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 1995;59(4):835–844.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA

    Agnes B. Kane MD, PhD

Authors
  1. Agnes B. Kane MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Thoracic Oncology, Barbara Ann Karmanos Cancer Institute, Harper University Hospital, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  2. Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  3. Nevada Cancer Institute, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  4. Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas, NV, 81935, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  5. Thoracic Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153, USA

    Michele Carbone MD, PhD (Professor of Pathology, Director) (Professor of Pathology, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Kane, A.B. (2005). Mesothelial and Mesothelioma Cell Lines. In: Pass, H.I., Vogelzang, N.J., Carbone, M. (eds) Malignant Mesothelioma. Springer, New York, NY. https://doi.org/10.1007/0-387-28274-2_5

Download citation

  • DOI: https://doi.org/10.1007/0-387-28274-2_5

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22949-2

  • Online ISBN: 978-0-387-28274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation